Tennessee Oncology
Al Lawson has a vast and varied work experience in the field of Radiation Oncology. Al is currently working as the Senior Vice President of Radiation Oncology Services at Tennessee Oncology since September 2016. Prior to that, they were the Founder of Advanced Radiation Oncology Consulting LLC, a global sole proprietorship firm providing consulting services in the field of Radiation Oncology hardware and software sales, clinical management, and product development. Al also served as the Director of Particle Therapy and Director of Research Collaborations at Elekta, where they were responsible for strategic business development, research collaborations, and regulatory submissions. Before joining Elekta, Al Lawson held the position of Director of Collaborations at CMS, Inc., and later at Elekta, Software after the acquisition. Al also worked as the Administrative Director of Radiation Oncology at Florida Hospital and as Director of Clinical Systems Sales at Varian Medical Systems. Moreover, they have had significant academic experience as an Associate Professor at the University of Alabama School of Medicine and as a Postdoctoral Fellow at the University of Iowa.
Al Lawson received a Bachelor of Science degree in Biology and Psychology from the University at Buffalo from 1968 to 1972. Al went on to obtain a Ph.D. in Radiation Biology from the same university, specifically from the Department of Oral Biology within the School of Dentistry, completing their studies between 1972 and 1977.
Tennessee Oncology
Tennessee Oncology is one of the nation’s largest community-based cancer care specialists and home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology’s mission remains unchanged: To provide access to high quality cancer care and the expertise of clinical research for all patients at convenient locations within their community and close to their home. To this day, our growing network of physicians and number of locations is based on this mission. In 2018, Tennessee Oncology joined OneOncology, a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the United States, as a founding practice partner. Physicians specializing in gynecologic oncology, palliative care, radiation oncology, and health psychology comprise our group. Tennessee Oncology provides a full range of diagnostic services, including oncology specific expertise in PET/CT and laboratory services. Clinic locations provide on-site chemotherapy treatments so that patients receive care in their community and close to their home. Our physicians utilize the latest in molecular diagnostics and profiling to choose treatments specific to the genetics of your cancer. Oncology research is the largest area of new drug development. Self -administered medications, those taken by mouth or injected by the patient, comprise approximately 40% of these investigative medications. Tennessee Oncology’s in house pharmacy, Park Pharmacy, stocks oncology and hematology medications not readily available at community retail pharmacies. A URAC accredited Specialty Pharmacy, Park provides insurance and benefits investigation, prior authorization services for insurance coverage, co-pay assistance through manufacturer or foundation programs, extensive medication education, and access to a pharmacist 24 hours a day, 7 days a week.